Skip to main content

LPZ 15 ap Pill - blue & pink capsule/oblong, 16mm

Pill with imprint LPZ 15 ap is Blue & Pink, Capsule/Oblong and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Ajanta Pharma USA Inc.

Lansoprazole is used in the treatment of Barrett's Esophagus; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Erosive Esophagitis; Gastritis/Duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LPZ 15 ap

Lansoprazole Delayed-Release

LPZ 15 ap
15 mg
Blue & Pink
16.00 mm
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ajanta Pharma USA Inc.
National Drug Code (NDC)
Inactive Ingredients
sucrose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, low substituted hydroxypropyl cellulose, magnesium carbonate, magnesium silicate, polyethylene glycol, hydroxypropyl cellulose, silicon dioxide, hypromelloses, ferric oxide red, ferrosoferric oxide, ferric oxide yellow, sodium bicarbonate, sodium lauryl sulfate, shellac, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.